Research indicates that GSDME plays a crucial part in sensitizing tumor cells to poly (ADP-ribose) polymerase inhibitors (PARPi), suggesting a potential avenue to enhance therapeutic efficacy in resistant cancers. Here, GSDME is linked to neoplasm.